Company / Net Debt per Share
Esperion Therapeutics, Inc. Net Debt per Share History
FY2016-FY2016 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Debt per Share
-$1.65
FY2016
5-year range
-
FY2016-FY2016
Trend
+51.4%
vs FY2015
Sector context
#64 of 82
Health Care
What the data says
Esperion Therapeutics, Inc.'s net debt per share of $-1.65 is lower than 78% of companies in the Health Care sector (FY2016).
Based on SEC 10-K filings.
-1.65 in FY2016.
Health Care sector context is included.
Net Debt per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 22% in Health CareTop 22% of 82This company -$1.65 Sector average $13.70
▼
-112.0% below sector average
Company context
Key Data Points
- Altman Z-Score -1.60 (distress zone, below 1.8 threshold)
- Negative profit margin: -15.6%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net Debt per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | -$1.65 | +51.4% |
As of FY2016 · SEC 10-K · Updated Jul 2, 2026